BackRBC Life Sciences Overview

RBC Life Sciences Net Tangible Assets

Track RBC Life Sciences's net tangible assets ($6.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$6.58M
↓ 9.65% YoYΔ $-702924.00 vs prior year quarter

Peer trimmed avg / median

Loading

RBC Life Sciences Net Tangible Assets History

Loading

RBC Life Sciences vs. peers: Net Tangible Assets Comparison

Loading

RBC Life Sciences Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RBC Life Sciences (RBCL) FAQ

As of the most recent data (September 2017), RBCL shows a net tangible assets of $6.6M. That compares with $7.3M in the prior-year period — down 9.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RBCL's net tangible assets is now $6.6M (was $7.3M) — a 9.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether RBC Life Sciences is outperforming or lagging.

Tracking RBCL's net tangible assets over time shows whether RBC Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6M That compares with $7.3M in the prior-year period — down 9.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has RBC Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $6.6M) with ownership activity and broader fundamentals.